Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biodel
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Established clinical diagnosis of type 1 diabetes, consistent with ADA classification criteria (Diabetes Care 35: S64-S71, 2012), for more than 1 year.
Age: 18 years old, or older.
Body Mass Index: between 18 and 35 kg/m2, inclusive.
Willing to use insulin glargine as the only basal insulin throughout the duration of the trial.
Willingness not to use insulin pump treatment and only use the study glucose meter and CGM devices during the duration of the trial.
You may not be if
History of known hypersensitivity to any of the components in the study medication
Treatment with pramlintide or GLP-1 analogs within 30 days of screening or anticipated use of these medications during the course of the study.
Treatment with oral or intravenous corticosteroids in the last 3 months prior to screening. Standard doses of inhalational corticosteroid used as part of a long term treatment regimen are allowed.
Consistent recent hypoglycemic unawareness within the last six months
History of more than two severe hypoglycemic events within six months prior to screening
